Eisai Co., Ltd.

4523.T
Drug Manufacturers - Specialty & Generic
2026/03/03 Updated
Market Cap: $9.2B (¥1.4T)
Stock Price: $32.63 (¥5,098)
Exchange Rate: 1 USD = ¥156.25

Stock Price Chart

2026/03/03 Updated
29.15
PER (Price Earnings Ratio)
vs Industry Avg: +19.6
1.62
PBR (Price to Book Ratio)
vs Industry Avg: +0.3
3.14%
Dividend Yield
vs Industry Avg: +0.19%

Price Trend

2026/03/03 Updated
Short-term
5-Day MA
-0.99%
Near-term
25-Day MA
+6.94%
Mid-term
75-Day MA
+8.84%
Long-term
200-Day MA
+14.16%

Price & Trading Details

2026/03/03 Updated

PRICE

Previous Close ¥5,241
Open ¥5,102
High ¥5,145
Low ¥5,045
Close ¥5,098

TRADING

Volume 1,245,100
Average Volume 1,365,791
Turnover ¥63億
Min. Purchase ¥509,800

Analyst Recommendations 12 analysts

Updated 2026/03/01
Strong Buy
0
Buy
4
4
Hold
7
7
Sell
0
Strong Sell
1
1
Target Price (Mean)
¥4,963
Buy
¥6,200
High
¥4,900
Median
¥3,600
Low
+11% vs Current Price
This information is based on market data from third-party data providers and is for reference only. Investment decisions are your own responsibility.

Shareholder Composition

Updated 2026/03/01
6.0%
Insider Holdings
53.6%
Institutional
40.4%
Public Float
278
Institutional Holders
Insider Holdings 6.0%
Institutional 53.6%
Public Float 40.4%

Top Mutual Funds / ETFs

Updated 2026/03/01

Major Holders

Updated 2026/03/01
Fund Name Ownership Shares Change
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund
2.92%
8.5M -11.67%
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
1.32%
3.8M -0.04%
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
0.84%
2.4M +2.35%
iShares Trust-iShares Core MSCI EAFE ETF
0.61%
1.8M 0.00%
HARTFORD MUTUAL FUNDS INC/CT-The Hartford International Value Fund
0.35%
1.0M +10.40%
Fidelity Concord Street Trust-Fidelity International Index Fund
0.32%
937.2K +1.42%
Institution Ownership Shares Change
Pacer Advisors, Inc.
<0.01%
2.3K -3.38%

Dividend History

Updated 2026/03/01
-%
Dividend Yield
¥160
Annual Dividend
0.0%
YoY Growth
97.7%
Payout Ratio
Year Dividend Change
2025 ¥160 0.0%
2024 ¥160 0.0%
2023 ¥160 0.0%
2022 ¥160 0.0%
2021 ¥160 -

Financial Performance

2026/03/01 Updated

Revenue & Profit

Margins

Cash Flow

Financial Health

2022 2023 2024 2025
Income Statement
Revenue ¥756,226M ¥744,402M ¥741,751M ¥789,400M
Gross Profit ¥581,395M ¥566,566M ¥586,417M ¥620,593M
Operating Income ¥53,750M ¥40,040M ¥53,407M ¥54,377M
Pretax Income ¥56,150M ¥47,278M ¥64,211M ¥64,584M
Net Income ¥47,954M ¥55,432M ¥42,407M ¥46,433M
EPS ¥167.25 ¥193.31 ¥147.86 ¥163.76
Operating Margin 7.11% 5.38% 7.20% 6.89%
Balance Sheet
Total Assets ¥1,239,315M ¥1,263,350M ¥1,393,799M ¥1,386,547M
Total Equity ¥748,821M ¥799,959M ¥875,614M ¥841,417M
Total Liabilities ¥490,494M ¥463,391M ¥518,185M ¥545,130M
Cash ¥309,633M ¥267,350M ¥304,678M ¥265,561M
Interest-bearing Debt ¥94,893M ¥126,105M ¥159,405M ¥187,523M
Equity Ratio 60.42% 63.32% 62.82% 60.68%
D/E Ratio 0.13 0.16 0.18 0.22
Cash Flow
Operating CF ¥117,590M -¥1,772M ¥55,993M ¥30,117M
Investing CF -¥28,848M -¥22,723M -¥25,321M -¥10,097M
Financing CF -¥48,967M -¥24,522M -¥22,720M -¥57,809M
Free CF ¥77,123M -¥36,331M ¥31,170M ¥7,148M
Efficiency
ROE 6.40% 6.93% 4.84% 5.52%
ROA 3.87% 4.39% 3.04% 3.35%

Latest IR Information

Latest News (5 items)

Company Information

English Name Eisai Co., Ltd.
Japanese Name エーザイ(株)
Stock Code 4523.T (JPX)
Sector / Industry Healthcare / Drug Manufacturers - Specialty & Generic
Website https://www.eisai.co.jp
Employees 10,917

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Data provided by Yahoo Finance